Myda Advisors LLC Trevena Inc Transaction History

Myda Advisors LLC

  • $407 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 10, 2018
SELL
$1.51 - $2.06 $33,390 - $45,552
-22,113 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$1.4 - $2.6 $30,958 - $57,493
22,113
22,113 $35,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $292M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email